And his former Spurs teammate, Keldon Johnson, is thrilled to see him back in the league. "Well deserved," said Johnson. "Everybody's path is different, but I'm extremely proud of Lonnie." ...

Keldon Johnson chipped in 28 points off the bench. The Spurs rallied after the deficit reached seven points with 1:36 to go in the game. Stephon Castle swished his 3-pointer then grabbed a board ...

The Philadelphia Eagles are trading safety C.J. Gardner-Johnson to the Houston Texans for guard Kenyon Green and a swap of draft picks, a person with knowledge of the deal told The Associated ...

COPENHAGEN - Genmab A/S (NASDAQ:GMAB) revealed Monday that Johnson & Johnson (J&J) will not pursue the option to license HexaBody-CD38 (GEN3014) for development and commercialization. Despite ...

Copenhagen-based biotech firm Genmab (CSE:GMAB) A/S disclosed today that Johnson & Johnson will not advance the HexaBody-CD38 program, as detailed in a recent SEC filing. The announcement was made in ...

COPENHAGEN, Denmark I March 10, 2025 I Genmab A/S (Nasdaq: GMAB) announced today that Johnson & Johnson (J&J) has decided that it will not exercise its option to receive a worldwide license to develop ...

COPENHAGEN, Denmark--(BUSINESS WIRE)-- Genmab A/S (Nasdaq: GMAB) announced today that Johnson & Johnson (J&J) has decided that it will not exercise its option to receive a worldwide license to ...

COPENHAGEN - Genmab A/S (NASDAQ:GMAB) revealed Monday that Johnson & Johnson (J&J) will not pursue the option to license HexaBody-CD38 (GEN3014) for development and commercialization. Despite ...

Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38 Genmab will not pursue further clinical ...